NCT01358851View on ClinicalTrials.gov

LAS41005 in Hyperkeratotic Actinic Keratosis

PHASE2CompletedINTERVENTIONAL
Enrollment

67

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

March 31, 2012

Study Completion Date

August 31, 2012

Conditions
Actinic Keratosis
Interventions
PROCEDURE

Cryotherapy

1-2 times during the treatment time

DRUG

LAS41005

once daily

Trial Locations (4)

42275

Almirall investigative site 2, Wuppertal

48249

Almirall investigative site 3, Dülmen

59494

Almirall investigative site 4, Soest

04107

Almirall investigative site 1, Leipzig

Sponsors

Lead Sponsor

Almirall, S.A.
All Listed Sponsors
lead

Almirall, S.A.

INDUSTRY

NCT01358851 - LAS41005 in Hyperkeratotic Actinic Keratosis | Biotech Hunter | Biotech Hunter